- Home
- CLRB vs ADGM Comparison
CLRB vs ADGM Comparison
Compare CLRB & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- ADGM
- Stock Information
- Founded
- CLRB 2002
- ADGM 2011
- Country
- CLRB United States
- ADGM United States
- Employees
- CLRB N/A
- ADGM N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- ADGM
- Sector
- CLRB Health Care
- ADGM
- Exchange
- CLRB Nasdaq
- ADGM NYSE
- Market Cap
- CLRB 12.8M
- ADGM 14.7M
- IPO Year
- CLRB N/A
- ADGM N/A
- Fundamental
- Price
- CLRB $0.32
- ADGM $1.08
- Analyst Decision
- CLRB Buy
- ADGM
- Analyst Count
- CLRB 2
- ADGM 0
- Target Price
- CLRB $28.00
- ADGM N/A
- AVG Volume (30 Days)
- CLRB 1.3M
- ADGM 162.3K
- Earning Date
- CLRB 03-13-2025
- ADGM 03-21-2025
- Dividend Yield
- CLRB N/A
- ADGM N/A
- EPS Growth
- CLRB N/A
- ADGM N/A
- EPS
- CLRB N/A
- ADGM N/A
- Revenue
- CLRB N/A
- ADGM $543,000.00
- Revenue This Year
- CLRB N/A
- ADGM N/A
- Revenue Next Year
- CLRB $208.14
- ADGM N/A
- P/E Ratio
- CLRB N/A
- ADGM N/A
- Revenue Growth
- CLRB N/A
- ADGM 187.30
- 52 Week Low
- CLRB $0.22
- ADGM $0.75
- 52 Week High
- CLRB $4.17
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- CLRB 51.53
- ADGM N/A
- Support Level
- CLRB $0.30
- ADGM N/A
- Resistance Level
- CLRB $0.34
- ADGM N/A
- Average True Range (ATR)
- CLRB 0.03
- ADGM 0.00
- MACD
- CLRB 0.01
- ADGM 0.00
- Stochastic Oscillator
- CLRB 65.14
- ADGM 0.00
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.